ALEXIS SHAFII to Treatment Outcome
This is a "connection" page, showing publications ALEXIS SHAFII has written about Treatment Outcome.
Connection Strength
0.229
-
Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation. ASAIO J. 2012 Sep-Oct; 58(5):526-9.
Score: 0.034
-
High incidence of upper-extremity deep vein thrombosis with dual-lumen venovenous extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):988-9.
Score: 0.034
-
Fate of retained right ventricular assist device outflow grafts after right ventricular recovery. J Heart Lung Transplant. 2012 Jun; 31(6):672-3.
Score: 0.033
-
Minimally Invasive Mitral Valve Surgery Using a Cold Fibrillatory Cardiac Arrest Technique in Patients With Prior Cardiac Surgery. Tex Heart Inst J. 2024 Jul 19; 51(2).
Score: 0.019
-
COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. J Heart Lung Transplant. 2023 01; 42(1):33-39.
Score: 0.017
-
Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. 2023 Dec; 26(4):275-286.
Score: 0.017
-
Preoperative hyponatremia and survival after left ventricular assist device implantation. Artif Organs. 2022 Sep; 46(9):1923-1931.
Score: 0.017
-
Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022 Mar; 25(1):16-23.
Score: 0.016
-
Impact of donor lung pathogenic bacteria on patient outcomes in the immediate post-transplant period. Transpl Infect Dis. 2018 Dec; 20(6):e12986.
Score: 0.013
-
Expanding the donor pool: donation after cardiac death. Thorac Surg Clin. 2015; 25(1):35-46.
Score: 0.010
-
Combined heart and liver transplantation: the Cleveland Clinic experience. Ann Thorac Surg. 2013 Jan; 95(1):179-82.
Score: 0.009
-
Images in cardiology. Ventricular outflow tract papillary fibroelastoma presenting with non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2010 Jun 08; 55(23):2607.
Score: 0.007
-
Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer. J Gastrointest Surg. 2000 Nov-Dec; 4(6):614-9.
Score: 0.004